前沿论文｜CELL INTELLIGENCE

Next-generation immune cell therapies for lung cancer: advances in CAR-T, NK, and TIL strategies.

PubMed 2026/03/04 发表Front Med (Lausanne)Q1 · IF 3.6（JCR 2025）

TIL expansion with high dose IL-2 or low dose IL-2 with anti-CD3/anti-CD28 stimulation provides different quality of TIL-expanded T cell clones.

PubMed 2022/01/31 发表J Immunol MethodsQ4 · IF 1.7（JCR 2025）

前沿论文 2